LANGLEBIGE POLYPEPTIDBINDUNGSMOLEKÜLE

European patent · EP2820047 · In force

Register entry

Publication number
EP2820047
Application number
EP13716734
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 1, 2013
Published
Jan 7, 2015
Granted
Apr 25, 2018
Protection ends at the latest
Feb 28, 2033
Next annual fee due
Mar 31, 2027
IPC classes
C07K 16/28 (2006.01)
Priority
US 201261605681 P 01.03.2012
US 201261606268 P 02.03.2012
PCT application
PCT/EP2013/054223 01.03.2013
PCT publication
WO2013/128027 06.09.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Apr 25, 2018

    Granted

    Published in Swissreg on 25.04.2018

Parties

Holder

Amgen Research (Munich) GmbH

Staffelseestrasse 2, 81477 München, DE

Inventor

KUFER, Peter

81477 Munich, DE

RAUM, Tobias

81477 Munich, DE

LUTTERBUESE, Ralf

81477 Munich, DE

HOFFMANN, Patrick

81477 Munich, DE

MUENZ, Markus

81477 Munich, DE

BROZY, Johannes

81477 Munich, DE

KVESIC, Majk

81477 Munich, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.